MENU
FBT
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

FBT stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index... Show more

Category: #Health
FBT
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for FBT with price predictions
Aug 21, 2026

FBT in +2.08% Uptrend, growing for three consecutive days on August 18, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where FBT advanced for three days, in of 339 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on FBT as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FBT just turned positive on August 10, 2026. Looking at past instances where FBT's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FBT broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for FBT entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Illumina (NASDAQ:ILMN), Biogen (NASDAQ:BIIB), Incyte Corp (NASDAQ:INCY), Exact Sciences Corp (NASDAQ:EXAS), Exelixis (NASDAQ:EXEL), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.

Market Cap

The average market capitalization across the First Trust NYSE Arca Biotech ETF ETF is 41.79B. The market cap for tickers in the group ranges from 1.98B to 237.52B. AMGN holds the highest valuation in this group at 237.52B. The lowest valued company is SRPT at 1.98B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust NYSE Arca Biotech ETF ETF was 129%. For the same ETF, the average monthly price growth was 150%, and the average quarterly price growth was 251%. MRNA experienced the highest price growth at 129%, while MTD experienced the biggest fall at -2%.

Volume

The average weekly volume growth across all stocks in the First Trust NYSE Arca Biotech ETF ETF was 228%. For the same stocks of the ETF, the average monthly volume growth was 226% and the average quarterly volume growth was 23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 72
P/E Growth Rating: 42
Price Growth Rating: 35
SMR Rating: 58
Profit Risk Rating: 58
Seasonality Score: -9 (-100 ... +100)
View a ticker or compare two or three
FBT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
First Trust Exchange-Traded Fund1001 Warrenville Road, Suite 300Lisle
Phone
630-241-4141
Web
www.ftportfolios.com